Last update: July 10, 2017
Minimal risk for breastfeeding and infant.
A modified gamma-cyclodextrin that binds to rocuronium or vecuronium, reversing its neuromuscular blocking action. Used intravenously.
Since the last update we have not found published data on its excretion in breast milk.
Side effects are rare and mild.
It is administered in single or isolated doses.
Its high molecular weight makes it unlikely that it will pass into milk in significant amounts.
Its low oral bioavailability would make it difficult its passage to the infant’s plasma through breast milk (EMA 2017).
Sugammadex can be used during breastfeeding (EMA 2017)
We do not have alternatives for Org-25969 since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.